Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DR26FT337
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,467 firm fixed price delivery order to AmerisourceBergen Drug Corp for Skyrizi 360 mg/2.4 ml on-body injectors on October 27, 2025, with completion targeted for November 18, 2025. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Skyrizi is a biologic medication used to treat inflammatory skin conditions, demonstrating the breadth of specialty pharmaceutical products AmerisourceBergen supplies through its federal contract portfolio.
AmerisourceBergen serves as a critical pharmaceutical distributor for the Defense Health Agency and other federal healthcare systems, leveraging its extensive IDC vehicle to deliver a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military and veteran healthcare programs worldwide. The company's demonstrated capability to fulfill federal medical procurement requirements through competitive awards and its significant prime vendor status position it as a primary supplier for pharmaceutical products essential to the military health system's operations.
Quick answers
Who was awarded contract SPE2DR26FT337?
SPE2DR26FT337 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DR26FT337 worth?
The government has obligated $12,467 on SPE2DR26FT337.
Is contract SPE2DR26FT337 an order under another contract?
Yes. SPE2DR26FT337 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT337 competed?
The extent of competition for SPE2DR26FT337 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award